News

Euroscreen and GNF will be engaged in research focused upon the development of therapeutic antibodies targeting G protein coupled receptors (GPCRs).

Activotec has been appointed by Matrix as European distributor for its range of high performance resins and supported reagents for solid phase peptide and organic chemistry.

Oxford scientists have developed a 3D Molecule Search Engine that can identify shape and search similar compounds from 3.5 billion molecule structures database.

Dalton will utilize medicinal chemistry expertise to design and synthesise compounds against antiviral targets selected by Boehringer Ingelheim (Canada).

Osiris reports the results of a double-blind, placebo-controlled study evaluating the safety and preliminary efficacy of the intravenous administration an adult mesenchymal stem cell therapy.

According to AstraZenec, the facility will strengthen the global PR&D programmes as well as provide support to the existing Drug Discovery programme at Bangalore.

The two companies will work to improve the MAbs pharmacokinetics and effectors functions, which play a key role in their therapeutic capacity.

Applied Biosystems and MDS Sciex have created a software development initiative to help pharmaceutical companies determine drug candidate viability early in development.

Applied Precision’s base instrument will be used to help create an imager that will be incorporated into NanoString’s nCounter System.

Eisai Corporation has signed a definitive agreement to acquire Morphotek® to expand its capabilities into the biologic therapeutics field.